Indoco Remedies Ltd.

NSE: INDOCO | BSE: 532612 | ISIN: INE873D01024 | Industry: Pharmaceuticals
| Momentum Trap
325.1000 -0.05 (-0.02%)
NSE Jul 09, 2025 09:19 AM
Volume: 5,215
 

325.10
-0.02%
Prabhudas Lilladhar
Rs3.1bn for FY23E, with strong India formulations growth. We revise our earnings estimate by downward by 2.6% for FY22E due to tepid performance of acute therapy medicines in IPM given the 2nd wave of pandemic. While, we increased estimates for FY23E by 2.5% in FY23E on back of increase in EUs growth projection. INDR's 3QFY21 revenue and PAT missed our estimates, due to sharper decline in India formulations and API...
Indoco Remedies Ltd. has gained 37.67% in the last 3 Months
More from Indoco Remedies Ltd.
Recommended